Worse outcome in stroke patients treated with rt-PA without early reperfusion: associated factors

Ver/Abrir
Use este enlace para citar
http://hdl.handle.net/2183/37243
Excepto si se señala otra cosa, la licencia del ítem se describe como Creative Commons Attribution 4.0 International License (CC-BY 4.0)
Colecciones
- Investigación (FCS) [1284]
Metadatos
Mostrar el registro completo del ítemTítulo
Worse outcome in stroke patients treated with rt-PA without early reperfusion: associated factorsAutor(es)
Fecha
2017-11-07Cita bibliográfica
Iglesias-Rey R, Rodríguez-Yáñez M, Rodríguez-Castro E, Pumar JM, Arias S, Santamaría M, López-Dequidt I, Hervella P, Correa-Paz C, Sobrino T, Vivien D, Campos F, Castellanos M, Castillo J. Worse outcome in stroke patients treated with rt-PA without early reperfusion: associated factors . Transl Stroke Res. 2018 Aug;9(4):347-355.
Resumen
[Abstract] Based on preclinical studies suggesting that recombinant tissue plasminogen activator (rt-PA) may promote ischemic brain injuries, we investigated in patients the possible risk of worse clinical outcome after rt-PA treatment as a result of its inability to resolve cerebral ischemia. Here, we designed a cohort study using a retrospective analysis of patients who received treatment with intravenous (4.5-h window) or intraarterial rt-PA, without or with thrombectomy. Controls were consecutive patients who did not receive recanalization treatment, who met all inclusion criteria. As a marker of reperfusion, we defined the variable of early neurological improvement as the difference between the score of the National Institute of Health Stroke Scale (NIHSS) (at admission and 24 h). The main variable was worsening of the patient's functional situation in the first 3 months. To compare quantitative variables, we used Student's t test or the Mann-Whitney test. To estimate the odds ratios of each independent variable in the patient's worsening in the first 3 months, we used a logistic regression model. We included 1154 patients; 577 received rt-PA, and 577 served as controls. In the group of patients treated with rt-PA, 39.4% who did not present clinical reperfusion data developed worsening within 3 months after stroke compared with 3.5% of patients with reperfusion (P < 0.0001). These differences were not significant in the control group. In summary, administration of rt-PA intravenously or intraarterially without reperfusion within the first 24 h may be associated with a higher risk of functional deterioration in the first 3 months.
Palabras clave
Blood-brain barrier
Critical care
Hemorrhage transformation
Ischemic stroke
Prognosis
Critical care
Hemorrhage transformation
Ischemic stroke
Prognosis
Versión del editor
Derechos
Creative Commons Attribution 4.0 International License (CC-BY 4.0)
ISSN
1868-4483